Sep 11 |
et al., Scientific Reports, doi:10.1038/s41598-024-72262-w | Astodrimer sodium nasal spray forms a barrier to SARS-CoV-2 in vitro and preserves normal mucociliary function in human nasal epithelium |
| In Vitro study showing that astodrimer sodium nasal spray forms an effective barrier against SARS-CoV-2 infection while preserving normal mucociliary function in human nasal epithelium. Authors demonstrated a 96.6% reduction in infectious.. | ||
Sep 6 |
et al., Pharmaceutics, doi:10.3390/pharmaceutics16091173 | Astodrimer Sodium Nasal Spray versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blinded, Placebo-Controlled Trial |
| 19% improved recovery (p=0.41) and 24% improved viral clearance (p=0.3). RCT 222 non-hospitalized low risk COVID-19 patients showing lower SARS-CoV-2 viral load, faster viral clearance, and improvements in symptoms, particularly anosmia, with astodrimer sodium nasal spray compared to placebo. The reduction in .. | ||
Jun 17 2022 |
et al., Scientific Reports, doi:10.1038/s41598-022-14601-3 | Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial |
| RCT 40 healthy volunteers showing astodrimer sodium 1% nasal spray was well tolerated with no systemic absorption detected. Treatment emergent adverse events occurred in a greater proportion of participants receiving placebo than astodrim.. | ||
Aug 20 2021 |
et al., Viruses, doi:10.3390/v13081656 | Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice |
| Mouse study showing astodrimer sodium 1% nasal spray significantly reduced SARS-CoV-2 replication, tissue viral loads, and proinflammatory cytokine production in K18-hACE2 mice. Astodrimer sodium reduced viral genome copies and infectious.. | ||
Jul 31 2021 |
et al., Antiviral Research, doi:10.1016/j.antiviral.2021.105089 | Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro |
| In Vitro study showing potent antiviral and virucidal activity of astodrimer sodium against SARS-CoV-2. | ||
Please send us corrections, updates, or comments.
c19early involves the extraction of 100,000+ datapoints from
thousands of papers. Community updates
help ensure high accuracy.
Treatments and other interventions are complementary.
All practical, effective, and safe
means should be used based on risk/benefit analysis.
No treatment or intervention is 100% available and effective for all current
and future variants.
We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.
Thanks for your feedback! Please search before submitting papers and note
that studies are listed under the date they were first available, which may be
the date of an earlier preprint.